CEACAM5 and cancer: As an example, Cohen et al. developed a liquid biopsy-based multi-cancer screening panel that integrates genetic mutations in cfDNA (across 1933 loci in 16 cancer-associated genes) with serum levels of eight protein biomarkers, including CA 125, CEA, and CA 19-9 [161].